Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. März 2015 16:14 ET | Quelle: Otonomy, Inc.

Otonomy Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update

SAN DIEGO, March 18, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
12. März 2015 08:00 ET | Quelle: Otonomy, Inc.

Otonomy to Report Fourth Quarter and Full Year 2014 Financial Results and Provide Corporate Update

SAN DIEGO, March 12, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
26. Februar 2015 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Submits New Drug Application to the FDA for AuriPro(TM)

SAN DIEGO, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
24. Februar 2015 08:00 ET | Quelle: Otonomy, Inc.

Otonomy to Present at Two Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
28. Januar 2015 16:02 ET | Quelle: Otonomy, Inc.

Otonomy Announces Closing of Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN DIEGO, Jan. 28, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
22. Januar 2015 20:34 ET | Quelle: Otonomy, Inc.

Otonomy Announces Pricing of Follow-on Public Offering

SAN DIEGO, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
21. Januar 2015 16:01 ET | Quelle: Otonomy, Inc.

Otonomy Announces Launch of Follow-on Public Offering

SAN DIEGO, Jan. 21, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
08. Januar 2015 17:29 ET | Quelle: Otonomy, Inc.

Otonomy Files Registration Statement for Proposed Follow-on Public Offering

SAN DIEGO, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
08. Januar 2015 16:55 ET | Quelle: Otonomy, Inc.

Otonomy Provides Corporate and Product Pipeline Update

SAN DIEGO, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
06. Januar 2015 08:00 ET | Quelle: Otonomy, Inc.

Otonomy to Present at the J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...

Vorherige Seite

Nächste Seite